Catalyst Wire Dossier Catalyst Wire Dossier

GHB01L1

· AVIR Green Hills Biotechnology AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GHB01L1, covering 2009-12-08 to 2009-12-08. Get the full timeline:

Most recent: Clinical Trial Update: Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers [Phase 1]

See pricing